Lara Perryman
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Microbial metabolism and enzyme function 4
- Protein Degradation and Inhibitors 2
- Ubiquitin and proteasome pathways 1
- Genetics 9
- Glioma Diagnosis and Treatment 9
- Co-authors
- Chris Jones (9 shared papers)Darren Hargrave (6 shared papers)Janine T. Erler (3 shared papers)Andrew D.J. Pearson (3 shared papers)Marta Viana‐Pereira (4 shared papers)Nathalie Gaspar (4 shared papers)Dorine A. Bax (4 shared papers)Suzanne E. Little (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Clinical Cancer Research (1 paper)Nuclear Medicine and Biology (1 paper)Scientific Reports (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United KingdomAustraliaDenmark
In The Last Decade
Lara Perryman
19 papers receiving 850 citations
Peers
Comparison fields: 5 of 67
- Genetics 302
- Cancer Research 163
- Neurology 97
- Molecular Biology 457
- Oncology 140
Countries citing papers authored by Lara Perryman
This map shows the geographic impact of Lara Perryman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Perryman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Perryman more than expected).
Fields of papers citing papers by Lara Perryman
This network shows the impact of papers produced by Lara Perryman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Perryman. The network helps show where Lara Perryman may publish in the future.
Co-authors
The 25 scholars most cited alongside Lara Perryman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 137 | |
| 2 | 2010 | 136 | |
| 3 | 2015 | 122 | |
| 4 | 2009 | 94 | |
| 5 | 2018 | 88 | |
| 6 | 2009 | 71 | |
| 7 | 2011 | 41 | |
| 8 | 2014 | 36 | |
| 9 | 1975 | 31 | |
| 10 | 2012 | 28 | |
| 11 | 2023 | 20 | |
| 12 | 2017 | 16 | |
| 13 | 2006 | 12 | |
| 14 | 2016 | 11 | |
| 15 | 2015 | 8 | |
| 16 | 2022 | 5 | |
| 17 | 2025 | 3 | |
| 18 | 2009 | 1 | |
| 19 | Differential mechanisms of temozolomide resistance in pediatric glioma cell lines | 2008 | 1 |
About Lara Perryman
Lara Perryman is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Neurology, having authored 19 papers that have together received 861 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (9 papers), Microbial metabolism and enzyme function (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), MRI in cancer diagnosis (2 papers), Protein Degradation and Inhibitors (2 papers), Neuroblastoma Research and Treatments (2 papers), Nitric Oxide and Endothelin Effects (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Genetics (302 citations), Cancer Research (163 citations), Neurology (97 citations), Molecular Biology (457 citations) and Oncology (140 citations). Lara Perryman has collaborated with scholars based in United Kingdom, Australia and Denmark. Frequent co-authors include Chris Jones, Darren Hargrave, Janine T. Erler, Andrew D.J. Pearson, Marta Viana‐Pereira, Nathalie Gaspar, Dorine A. Bax, Suzanne E. Little, Rui Manuel Reis and Lynley V. Marshall. Their work appears in journals such as Biochemical and Biophysical Research Communications, Clinical Cancer Research, Nuclear Medicine and Biology, Scientific Reports and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.